1620 Investment Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.6K Sell
188
-25
-12% -$4.17K 0.02% 382
2026
Q1
$44.7K Buy
213
+9
+4% +$2.26K 0.03% 314
2025
Q4
$58K Hold
204
0.04% 286
2025
Q3
$63K Sell
204
-3
-1% -$940 0.04% 274
2025
Q2
$65K Sell
207
-1
-0.5% -$289 0.05% 280
2025
Q1
$54.6K Sell
208
-21
-9% -$5.68K 0.04% 287
2024
Q4
$59.8K Buy
229
+3
+1% +$756 0.05% 280
2024
Q3
$52.6K Sell
226
-32
-12% -$6.57K 0.04% 290
2024
Q2
$52.1K Buy
+258
New +$46.5K 0.04% 288

Other funds holding PODD

1620 Investment Advisors's PODD Position: Q2 2026 in Review

1620 Investment Advisors reduced its Insulet (PODD) stake by 12% in Q2 2026, selling an estimated $4.17K and leaving 188 shares worth $28.6K. The position accounts for 0.02% of the portfolio, ranked #382.

1620 Investment Advisors first reported a position in PODD in Q2 2024 and has held it in 9 quarters since. The position peaked at $65K in Q2 2025. 110 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • 1620 Investment Advisors held 188 shares of Insulet worth $28.6K as of Q2 2026.
  • 1620 Investment Advisors sold 25 Insulet shares in Q2 2026, an estimated $4.17K.
  • Insulet made up 0.02% of 1620 Investment Advisors's portfolio in Q2 2026, its #382 holding.
  • 1620 Investment Advisors first reported a position in Insulet in Q2 2024 and has held it in 9 quarters since.
  • 1620 Investment Advisors's Insulet position peaked at $65K in Q2 2025.
  • 110 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.